Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001937792 | SCV002184993 | pathogenic | Glycogen storage disease, type II | 2023-06-06 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1407438). This premature translational stop signal has been observed in individual(s) with Pompe disease (PMID: 33560568; Invitae). This variant is present in population databases (rs762060817, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Glu537Glyfs*41) in the GAA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAA are known to be pathogenic (PMID: 18425781, 22252923). |
Ce |
RCV003458105 | SCV004185085 | pathogenic | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | GAA: PVS1, PM3:Strong, PM2 |